Literature DB >> 15150680

Thrombocytopenia and fatality associated with olanzapine.

Juan Antonio Carrillo, José Antonio González, Guillermo Gervasini, Rosa López, María Angeles Fernández, Guillermo Martín Núñez.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15150680     DOI： 10.1007/s00228-004-0772-x

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN： 0031-6970            Impact factor:   2.953


× No keyword cloud information.
  12 in total

1.  Thrombocytopenia possibly associated with olanzapine and subsequently with benztropine mesylate.

Authors:  O Bogunovic; R Viswanathan
Journal:  Psychosomatics       Date:  2000 May-Jun       Impact factor: 2.386

2.  Applicability of an assay for routine monitoring of highly variable concentrations of olanzapine based on HPLC with mass spectrometric detection.

Authors:  Guillermo Gervasini; Sonia Vizcaíno; Angustias G Herráiz; Julio Benítez; Juan Antonio Carrillo
Journal:  Clin Chem       Date:  2003-12       Impact factor: 8.327

3.  Olanzapine-induced neutropenia: mechanism and treatment.

Authors:  Harpreet S Duggal; Charlie Gates; Praveen C Pathak
Journal:  J Clin Psychopharmacol       Date:  2004-04       Impact factor: 3.153

4.  Olanzapine-induced thrombocytopenia in association with idiopathic thrombocytopenic purpura.

Authors:  S Bachmann; J Schröder; J Pantel; C Mundt; M Zorn; M Witzens; G Egerer
Journal:  Br J Psychiatry       Date:  1998-10       Impact factor: 9.319

5.  Dose-dependent olanzapine-associated leukopenia: three case reports.

Authors:  A Kodesh; B Finkel; A G Lerner; G Kretzmer; M Sigal
Journal:  Int Clin Psychopharmacol       Date:  2001-03       Impact factor: 1.659

6.  Two cases of olanzapine-induced reversible neutropenia.

Authors:  A Steinwachs; R Grohmann; F Pedrosa; E Rüther; I Schwerdtner
Journal:  Pharmacopsychiatry       Date:  1999-07       Impact factor: 5.788

Review 7.  Olanzapine: an updated review of its use in the management of schizophrenia.

Authors:  N Bhana; R H Foster; R Olney; G L Plosker
Journal:  Drugs       Date:  2001       Impact factor: 9.546

8.  Role of the smoking-induced cytochrome P450 (CYP)1A2 and polymorphic CYP2D6 in steady-state concentration of olanzapine.

Authors:  Juan Antonio Carrillo; Angustias G Herráiz; Sara Isabel Ramos; Guillermo Gervasini; Sonia Vizcaíno; Julio Benítez
Journal:  J Clin Psychopharmacol       Date:  2003-04       Impact factor: 3.153

9.  Heparin-associated thrombocytopenia: isolation of the antibody and characterization of a multimolecular PF4-heparin complex as the major antigen.

Authors:  A Greinacher; B Pötzsch; J Amiral; V Dummel; A Eichner; C Mueller-Eckhardt
Journal:  Thromb Haemost       Date:  1994-02       Impact factor: 5.249

10.  Drug-specific characteristics of thrombocytopenia caused by non-cytotoxic drugs.

Authors:  U Pedersen-Bjergaard; M Andersen; P B Hansen
Journal:  Eur J Clin Pharmacol       Date:  1998 Nov-Dec       Impact factor: 2.953
View more
  3 in total

1.  Olanzapine and pancytopenia with severe folate deficiency.

Authors:  F Maurier; N Petitpain; J-F Guichard; L Javot; P Tréchot
Journal:  Eur J Clin Pharmacol       Date:  2010-02-06       Impact factor: 2.953

2.  Olanzapine-associated leukopenia and thrombocytopenia managed with lithium in a patient who developed leukopenia with clozapine in the past: a case report.

Authors:  Sandeep Grover; Aditya Hegde; Munish Agarwal; Manupdesh Singh Sachdeva
Journal:  Prim Care Companion CNS Disord       Date:  2012

3.  Thrombocytopenia associated with olanzapine: A case report and review of literature.

Authors:  Swapnajeet Sahoo; Himanshu Singla; M Spoorty; Pankaj Malhotra; Sandeep Grover
Journal:  Indian J Psychiatry       Date:  2016 Jul-Sep       Impact factor: 1.759
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.